Clinical Trial Update: Induction of Stable Chimerism for Sickle Cell Anemia [Phase 2]

View source ↗

Summary

A Phase 2 NHLBI-sponsored trial evaluating induction of stable chimerism for sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Disease, Hematopoietic Stem Cell Transplantation | Phase 2 | Status: COMPLETED